Healio Minute

In this edition, light physical activity linked to lower cancer risk, lung lesion diagnostic yield from bronchoscopy and more. Read the full coverage here: 'Every bit of movement counts': Even light physical activity linked to lower cancer risk Robotic, electromagnetic navigation bronchoscopy have similar lung lesion diagnostic yield Women with history of adverse pregnancy outcomes face elevated r...

In this edition, IBD social risks linked to unplanned ED use, anal cancer screening for men with HIV may cut deaths by 65% and more. Read the full coverage here: Nearly two-thirds of adults with IBD experience social risks linked to unplanned ED use Anal cancer screening at age 35 for gay, bisexual men with HIV may cut deaths by 65% 'Not just a physical issue': CRC linked to adverse sexual health...

In this edition, we look at knee replacement survivorship, how DEI statements may lead to more women in sports medicine programs and more. Read the full coverage here: Public DEI statements may lead to more women faculty, fellows in sports medicine programs Knee replacements have high long-term survivorship in young patients Aragonite-based scaffold yielded similar outcomes between men, women with...

In this edition, DREAM program 'better than anything' available, maintenance regimen a potential new standard and more. Read the full coverage here: DREAM program 'better than anything' available for patients with advanced lung cancer Maintenance regimen a potential new standard in extensive-stage small cell lung cancer 'It can save their lives': Annual lung cancer screening improves cancer detect...

In this edition, reduction efforts prevent 3.8 million lung cancer deaths since 1970, first-line combination should be 'new standard' in advanced lung cancer and more. Read the full coverage here: Smoking cessation, reduction efforts prevent 3.8 million lung cancer deaths since 1970 First-line combination should be 'new standard' in advanced lung cancer Only 1 in 5 people treated with immune check...

In this edition, reduction efforts prevent 3.8 million lung cancer deaths since 1970, first-line combination should be 'new standard' in advanced lung cancer and more. Read the full coverage here: Smoking cessation, reduction efforts prevent 3.8 million lung cancer deaths since 1970 First-line combination should be 'new standard' in advanced lung cancer Only 1 in 5 people treated with immune check...

In this edition, sick food service workers top driver of viral foodborne outbreaks in US, no weight loss benefit with semaglutide before bariatric surgery and more. Read the full coverage here: Sick food service workers remain top driver of viral foodborne outbreaks in US 'We have work to do': No weight loss benefit with semaglutide before bariatric surgery Mailed FIT outreach program boosts color...

In this edition, recurrence-free survival estimates in less advanced lung cancer, bronchoscopy-guided microwave ablation safe in lung abnormality and more. Read the full coverage here: Recurrence-free survival estimates after surgery higher in less advanced lung cancer Electromagnetic navigation bronchoscopy-guided microwave ablation safe in lung abnormality High prevalence of atherosclerosis dete...

In this edition, robotic-assisted bronchoscopy a 'game changer', global mortality related to tobacco drops, particulate matter rises and more. Read the full coverage here: Robotic-assisted bronchoscopy a 'game changer' in early diagnosis of lung cancer Global lung cancer mortality related to tobacco drops, particulate matter rises in 2019 Osimertinib linked to more therapy-related cardiac events t...

In this edition, combination extends survival vs. standard first-line therapy, integrated care for smoking cessation during lung cancer screening and more. Read the full coverage here: Combination extends survival vs. standard first-line therapy for advanced lung cancer Integrated care 'best treatment option' for smoking cessation during lung cancer screening FDA proposes cap on nicotine levels in...

In this edition, we bring you Healio's top lung cancer headlines in 2024. Read the full coverage here: California doctor with lung cancer receives first-of-its-kind lung-liver transplant 'We were shocked': Vaping considerably increases lung cancer risk among people who smoke FDA places hold on trial of cell therapy for lung cancer after patient death Findings highlight 'desperate need' to improve...

In this edition, single-fraction SBRT outcomes for central lung tumors, adjuvant durvalumab extends survival in limited-stage small cell lung cancer and more. Read the full coverage here: Single-fraction SBRT confers 'surprisingly excellent' outcomes for central lung tumors Adjuvant durvalumab extends survival in limited-stage small cell lung cancer Depression among people with head and neck cance...

In this edition, FDA approves Rybrevant for advanced lung cancer, screening orders in eligible patients higher with digital health program and more. Read the full coverage here: FDA approves Rybrevant for advanced lung cancer Lung cancer screening orders in eligible patients higher with digital health program FDA approves Opdivo regimen for resectable NSCLC Study quantifies survival benefit of imm...

In this edition, blue-collar workers more likely to miss work or quit due to psoriatic arthritis, infliximab biosimilar increase after release of a third option and more. Read the full coverage here: Blue-collar workers more likely to miss work, quit due to psoriatic arthritis Infliximab biosimilar uptake rapidly increased only after release of a third option National Psoriasis Foundation to honor...

In this edition, FDA approves first subcutaneous anti-PD-L1 cancer immunotherapy, ivonescimab 'may be a new standard' and more. Read the full coverage here: FDA approves first subcutaneous anti-PD-L1 cancer immunotherapy Ivonescimab extends PFS vs. pembrolizumab in advanced NSCLC, may be 'a new standard' Perioperative nivolumab improves outcomes in resectable NSCLC Despite progress, barriers to lu...

In this edition, FDA approves first subcutaneous anti-PD-L1 cancer immunotherapy, Ivonescimab 'may be a new standard' and more. Read the full coverage here: FDA approves first subcutaneous anti-PD-L1 cancer immunotherapy Ivonescimab extends PFS vs. pembrolizumab in advanced NSCLC, may be 'a new standard' Perioperative nivolumab improves outcomes in resectable NSCLC Despite progress, barriers to lu...

In this edition, enrollment and dosing complete in phase 1 trial of AIV007, popular benchmarks in clinical practice guidelines and more. Read the full coverage here: Enrollment, dosing complete in phase 1 trial of AIV007 for AMD, diabetic macular edema OCT, visual acuity popular benchmarks in clinical practice guidelines for DME First patient dosed in phase 2 trial of EC-104 implant for diabetic m...

In this edition, drug discounts through Medicare price negotiations, opioid use has fallen 15% annually since 2014 and more. Read the full coverage here: Enbrel, Stelara to be discounted nearly 70% through Medicare price negotiations Opioid use has fallen 15% annually since 2014 in autoimmune rheumatic disease Inhibitor class PsO treatments exhibit similar efficacy in mitigating PsA risk S100 prot...

In this edition, low education level raises follow-up risk in screening program, screening judgement strongly influenced by clinicians and more. Read the full coverage here: Low education level raises risk for loss to follow-up in lung cancer screening program Lung cancer screening judgement strongly influenced by clinicians Occupational benzene exposure heightens lung cancer likelihood Chemothera...

In this edition, sozinibercept combination therapy shows durability, comparable improvements with aflibercept and more. Read the full coverage here: Sozinibercept combination therapy shows durability in patients with DME, neovascular AMD VIDEO: Comparable improvements seen with aflibercept 8 mg vs. 2 mg in DME DPP-IV, SGLT2 and GLP-1 drugs do not increase risk for diabetic macular edema Eluminex d...

In this edition, guselkumab brings 'stringent' control through 2 years, SARDs outpatient visits result in opioid prescriptions and more. Read the full coverage here: Guselkumab brings active psoriatic arthritis into 'stringent' control through 2 years Nearly one-quarter of all SARDs outpatient visits in US result in opioid prescription FDA approves biosimilar Pyzchiva for all approved Stelara indi...

In this edition, atezolizumab benefits PD-L1-selected patients with NSCLC, risks persist with e-cigarette use after quitting tobacco smoking and more. Read the full coverage here: Adjuvant atezolizumab benefits PD-L1-selected patients with NSCLC Lung cancer risks persist with e-cigarette use after quitting tobacco smoking COPD, IPF end of life health care use differs from lung cancer Tecentriq com...

In this edition, FDA approves Vabysmo prefilled syringe for retinal diseases, 4D Molecular Therapeutics updates on retinal disease candidates and more. Read the full coverage here: FDA approves Vabysmo prefilled syringe for retinal diseases VIDEO: 4D Molecular Therapeutics shares update on retinal disease candidates FDA approves Eylea biosimilar FYB203/Ahzantive VIDEO: Oral therapy improves centra...

In this edition, extensive psoriasis and IBD history predict difficult-to-treat psoriatic arthritis, targeted therapies demonstrate low risk for serious infection and more. Read the full coverage here: Extensive psoriasis, IBD history predict difficult-to-treat psoriatic arthritis Targeted psoriatic arthritis therapies demonstrate low risk for serious infection VIDEO: Dermatologists, rheumatologis...